Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001890784-25-000003
Filing Date
2025-09-19
Accepted
2025-09-19 16:45:00
Documents
1
Period of Report
2025-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1758314696.html 4  
1 FORM 4 wk-form4_1758314696.xml 4 3999
  Complete submission text file 0001890784-25-000003.txt   5582
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address
Anand Bhaskar (Reporting) CIK: 0001890784 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 251327387